Clinical Trial Update: Standard Moderately Hypofractionated RT vs. Ultra-hypofractionated Focal Lesion Ablative Microboost in Prostate Cancer [NA]

View source ↗

Summary

The document describes an ongoing clinical trial comparing standard moderately hypofractionated radiotherapy to ultra-hypofractionated focal lesion ablative mic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: The Netherlands Cancer Institute | Conditions: Prostate Cancer | NA | Status: RECRUITING